The following pages link to Siddhartha P. Chakrabarty (Q375584):
Displaying 44 items.
- Dynamics of hepatitis C under optimal therapy and sampling based analysis (Q375585) (← links)
- Global stability of one and two discrete delay models for chronic hepatitis B infection with HBV DNA-containing capsids (Q520303) (← links)
- Additional food induced Turing patterns for a diffusive predator-prey model (Q722697) (← links)
- Pricing and estimates of Greeks for passport option: A three time level approach (Q729847) (← links)
- A comparative study of bioeconomic ratio-dependent predator-prey model with and without additional food to predators (Q747984) (← links)
- Hopf bifurcation and stability switches induced by humoral immune delay in hepatitis C (Q828950) (← links)
- Chronic hepatitis B infection and HBV DNA-containing capsids: modeling and analysis (Q907619) (← links)
- A predator-prey model with additional food supply to predators: dynamics and applications (Q1655409) (← links)
- Modelling hepatitis C virus infection and the development of hepatocellular carcinoma (Q1784752) (← links)
- Pricing European passport option with radial basis function (Q1791773) (← links)
- Analysis of hepatitis C viral dynamics using Latin hypercube sampling (Q1948250) (← links)
- Analysis of a reaction-diffusion HCV model with general cell-to-cell incidence function incorporating B cell activation and cure rate (Q2060301) (← links)
- A quantitative study on the role of TKI combined with Wnt/\(\beta\)-catenin signaling and IFN-\(\alpha\) in the treatment of CML through deterministic and stochastic approaches (Q2120382) (← links)
- Is being ``robust'' beneficial? A perspective from the Indian market (Q2166065) (← links)
- Stochastic analysis of in-host HCV dynamics through budding and bursting process (Q2205386) (← links)
- Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity (Q2207871) (← links)
- Does marginal VaR lead to improved performance of managed portfolios: a study of S\&P BSE 100 and S\&P BSE 200 (Q2216399) (← links)
- Distributed parameters deterministic model for treatment of brain tumors using Galerkin finite element method (Q2270537) (← links)
- Valuation of American passport option using a three-time level scheme (Q2322412) (← links)
- (Q2718583) (← links)
- Pricing of Path-Dependent European-Type Options Using Monte Carlo Simulation (Q2789094) (← links)
- A CONTROL THEORY APPROACH TO CANCER REMISSION AIDED BY AN OPTIMAL THERAPY (Q3186161) (← links)
- Global stability and a non-standard finite difference scheme for a diffusion driven HBV model with capsids (Q3448522) (← links)
- OPTIMALLY CONTROLLED TREATMENT STRATEGY USING INTERFERON AND RIBAVIRIN FOR HEPATITIS C (Q3465764) (← links)
- (Q4006068) (← links)
- (Q4006069) (← links)
- (Q4006070) (← links)
- (Q4006071) (← links)
- (Q4006072) (← links)
- (Q4006073) (← links)
- (Q4006074) (← links)
- (Q4006075) (← links)
- (Q4006076) (← links)
- (Q4292539) (← links)
- (Q4292540) (← links)
- (Q4292541) (← links)
- (Q4292550) (← links)
- (Q4292554) (← links)
- (Q4292570) (← links)
- (Q4292571) (← links)
- (Q4323244) (← links)
- (Q4325054) (← links)
- Optimal portfolio and consumption subject to multidimensional economic factors (Q4908872) (← links)
- MODELING THE DYNAMICS OF COVID-19 TRANSMISSION IN INDIA: SOCIAL DISTANCING, REGIONAL SPREAD AND HEALTHCARE CAPACITY (Q5045126) (← links)
